Thomas N. Eade is an oncologist based in Sydney, NSW, Australia. He looks after people dealing with a range of cancers and some related conditions. His work is centred on treatment planning, helping people understand options, and supporting them through what can be a stressful time.
In many cases, his patients come to him for care around prostate cancer. This can include treatment after surgery (like prostatectomy) and ongoing management when cancer has spread or needs extra treatment. He also sees people with cancers of the thyroid, including anaplastic thyroid cancer, as well as other thyroid cancer cases.
Thomas also works with people who have head and neck squamous cell carcinoma (HNSCC). That might involve discussions about treatment choices, follow-up care, and what to expect over the coming months. For lung cancer, he supports patients dealing with lung tumours and lung metastases, helping them map out next steps based on their situation.
Another part of his practice involves muscle invasive bladder cancer. At times, he also helps manage difficult symptoms and complications that can come along with pelvic conditions, including proctitis. He has experience supporting patients who have spinal tumours too, where balancing treatment and quality of life matters a lot.
Not all of the conditions in his care are classic “solid tumour” cancers. He also treats patients with desmoid tumour and fibromatosis. These are less common conditions, and the right plan can take careful review because they can behave differently from person to person.
Over time, care like this needs strong teamwork. Thomas works with other specialists and healthcare teams to help coordinate treatment. He also stays across new research that can affect care, including ways some patients may access treatments through clinical trials.
Clinical trials can be an option for some people, depending on what’s going on medically. Where trials are relevant, they can help patients consider newer treatments under close monitoring. This can be part of the conversation during planning and follow-up, along with more standard treatment pathways.
